(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Private Equity Industry Banner
Mouse Scroll Icon
November 2022

Code Biotherapeutics, Inc. Appoints Alex S. Tracy as Chief Technical Officer

Code Biotherapeutics, Inc. announced the appointment of Alex Tracy as Chief Technical Officer. Alex will be responsible for developing Code Bio’s overall technical and manufacturing strategy, as well as building and leading a team to manage all stages of manufacturing, quality control, supply chain, and CMC facilities management. He will also play an integral role in delivering Code Bio’s proprietary, innovative, non-viral gene delivery technology and product pipeline. Alex joins Code Bio from BridgeBio Gene Therapy, where he served as Chief Technical Officer, directing process and analytical development and external manufacturing for several clinical-stage adeno-associated virus gene therapy programs. Prior to his role at BridgeBio Gene Therapy, Alex led the technical, Regulatory, and QA organizations at Istari Oncology.

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.